Yat Sun Or
Overview
Yat Sun Or received an average of $1M in total compensation, including $404K in salary, at Enanta Pharmaceuticals from 2011 to 2022.
2022Enanta PharmaceuticalsSenior Vice President, Research Development and Chief Scientific Officer
2021Enanta PharmaceuticalsSenior Vice President, Research & Development, Chief Scientific Officer
2020Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2019Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2018Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2017Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2016Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2015Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2014Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
2013Enanta PharmaceuticalsSenior Vice President, Research & Development and Chief Scientific Officer
Source: SEC filings on January 20, 2023, January 21, 2022, January 21, 2021, January 17, 2020, January 18, 2019, January 19, 2018, January 6, 2017, January 13, 2016, January 15, 2015, and January 10, 2014.
Related executives
We found seven more executives who work or worked at Enanta Pharmaceuticals.
Jay Luly
Enanta Pharmaceuticals
Chief Executive Officer
Scott Rottinghaus
Enanta Pharmaceuticals
Chief Medical Officer
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
Nathalie Adda
Enanta Pharmaceuticals
Chief Medical Officer
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019